In the last week, the United States market has been flat, yet it has experienced a remarkable 31% increase over the past year with earnings forecasted to grow by 15% annually. In this environment, identifying high growth tech stocks involves looking for companies that can sustain robust growth and innovation in line with these promising market conditions.
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Super Micro Computer | 20.63% | 25.42% | ★★★★★★ |
Sarepta Therapeutics | 23.80% | 44.01% | ★★★★★★ |
TG Therapeutics | 34.66% | 56.48% | ★★★★★★ |
Invivyd | 47.87% | 67.72% | ★★★★★★ |
Amicus Therapeutics | 20.26% | 62.89% | ★★★★★★ |
Alkami Technology | 21.90% | 98.60% | ★★★★★★ |
Alnylam Pharmaceuticals | 22.41% | 70.53% | ★★★★★★ |
Travere Therapeutics | 31.20% | 72.26% | ★★★★★★ |
Seagen | 22.57% | 71.80% | ★★★★★★ |
ImmunoGen | 26.00% | 45.85% | ★★★★★★ |
Click here to see the full list of 241 stocks from our US High Growth Tech and AI Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Vertex, Inc. offers enterprise tax technology solutions for the retail trade, wholesale trade, and manufacturing industries both in the United States and internationally, with a market cap of approximately $6.57 billion.
Operations: Vertex, Inc. generates revenue primarily from its software and programming segment, amounting to $617.83 million. The company specializes in providing tax technology solutions across various industries globally.
Vertex, Inc. has demonstrated a robust trajectory in the tech sector, notably with a 12.9% forecasted annual revenue growth outpacing the US market's 8.8%. This growth is underpinned by significant advancements in R&D, with expenses strategically allocated to foster innovations like the integration of Vertex for Salesforce Revenue Cloud, enhancing tax compliance and operational efficiency for businesses. Furthermore, Vertex's earnings are expected to surge by 36.8% annually, reflecting potent future prospects despite recent challenges such as a substantial one-off loss of $7.7 million affecting financial outcomes. The firm's strategic focus on expanding its cloud-based solutions is evident from its latest guidance update, projecting cloud revenue growth at an impressive rate of 28%, positioning it well within the competitive tech landscape.
Examine Vertex's past performance report to understand how it has performed in the past.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for patients with genomically defined cancers, with a market cap of $1.49 billion.
Operations: Day One Biopharmaceuticals focuses on developing targeted cancer therapies, with a market capitalization of approximately $1.49 billion. The company is in the clinical stage and does not currently report revenue streams.
Day One Biopharmaceuticals has pivoted from a substantial net loss to reporting a net income of $37.04 million in Q3 2024, signaling potential recovery and growth. This turnaround is underscored by an impressive expected annual revenue growth rate of 39.4%, significantly outpacing the broader US market's 8.8%. Moreover, the company's commitment to innovation is evident from its R&D investments, which are crucial as it gears up for profitability with earnings projected to surge by 67.3% annually. These strategic moves could position Day One well within the competitive biotech landscape, despite current unprofitability and past shareholder dilution.
Explore historical data to track Day One Biopharmaceuticals' performance over time in our Past section.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: DoubleVerify Holdings, Inc. offers a software platform focused on digital media measurement and data analytics both in the United States and globally, with a market capitalization of approximately $2.98 billion.
Operations: DoubleVerify Holdings generates revenue primarily from its data processing services, amounting to $612.88 million. The company's business centers around providing digital media measurement and analytics solutions on a global scale.
DoubleVerify Holdings (DV) is demonstrating robust growth with revenue and earnings forecasted to rise by 14% and 21.1% per year, respectively, outpacing the broader US market. This growth trajectory is supported by strategic integrations with platforms like Snap and Spotify, enhancing DV's media quality measurement services. These partnerships leverage DV’s AI-driven technology to ensure brand safety, boosting advertiser confidence and potentially increasing market share in the digital advertising space. Moreover, DV's recent expansion into LinkedIn's premium video inventory underscores its commitment to broadening its service capabilities, which could further solidify its position in a competitive industry.
Assess DoubleVerify Holdings' past performance with our detailed historical performance reports.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGM:VERX NasdaqGS:DAWN and NYSE:DV.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.